MRC1 and pulmonary fibrosis: Last, in vivo validation using a mouse model of bleomycin-induced lung fibrosis (Fig. 10A) confirmed the expression of β3 integrin in CD206-positve profibrotic Mφ 7 and 21 days after treatment but not in alveolar Mφ of saline-treated control lungs (Fig. 10B).